Artemis Investment Management’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q2 | – | Sell |
-54,457
| Closed | -$6.41M | – | 253 |
|
2022
Q1 | $6.41M | Sell |
54,457
-12,186
| -18% | -$1.43M | 0.05% | 203 |
|
2021
Q4 | $8.63M | Buy |
+66,643
| New | +$8.63M | 0.06% | 197 |
|
2020
Q4 | – | Sell |
-213,322
| Closed | -$17M | – | 268 |
|
2020
Q3 | $17M | Buy |
213,322
+127,018
| +147% | +$10.1M | 0.21% | 135 |
|
2020
Q2 | $5.97M | Sell |
86,304
-2,943
| -3% | -$204K | 0.08% | 203 |
|
2020
Q1 | $5.62K | Buy |
89,247
+18
| +0% | +$1 | 0.01% | 166 |
|
2019
Q4 | $6.94M | Sell |
89,229
-7,677
| -8% | -$597K | 0.09% | 184 |
|
2019
Q3 | $7.09M | Sell |
96,906
-27,189
| -22% | -$1.99M | 0.1% | 193 |
|
2019
Q2 | $7.65M | Sell |
124,095
-82,320
| -40% | -$5.07M | 0.09% | 207 |
|
2019
Q1 | $13.2M | Sell |
206,415
-92,631
| -31% | -$5.91M | 0.15% | 173 |
|
2018
Q4 | $15.3M | Buy |
+299,046
| New | +$15.3M | 0.2% | 138 |
|